TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd. is a specialty pharmaceutical company based in Zhubei, Taiwan, incorporated in 2011. It develops and commercializes small molecules for chronic organ inflammation associated with metabolic, autoimmune, and infectious causes. Its pipeline includes JKB-122 and JKB-121, as well as novel chemical entities for chronic liver diseases and allergy/asthma. Target indications include liver inflammation and fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis.